PBMs

The Federal Trade Commission on Wednesday finalized a major settlement with Cigna Group’s (NYSE:CI) pharmacy benefit manager Express Scripts, aimed at dismantling anticompetitive practices that have historically inflated the cost of medications. • Cigna Group shares are climbing with...

A heated debate over the U.S. healthcare system erupted on X, pitting billionaire entrepreneur Mark Cuban against Sen. Elizabeth Warren (D-Mass) over the root causes of soaring drug prices. What Happened: The clash, unfolding as of Friday, has reignited discussions on Pharmacy Benefit Managers (...

Billionaire entrepreneur Mark Cuban has proposed a bold plan to revolutionize the U.S. healthcare system, eliminating traditional insurance premiums and introducing transparent pricing. What Happened: Cuban’s recent proposal, posted on social media platform X, comes amid growing frustration...

Mark Cuban, the billionaire entrepreneur, challenged Trump-supporter and political activist Charlie Kirk‘s stance on high drug prices, asserting that Pharmacy Benefit Managers (PBMs) are the main culprits, not Big Pharma. What Happened: Cuban criticized Kirk’s focus on Big...

Shares of Pharmacy-benefit managers (PBMs) including CVS Health Corp (NYSE:CVS), UnitedHealth Group Inc (NYSE:UNH) and Cigna Group (NYSE:CI) are moving lower Tuesday on continued downside pressure following aggressive commentary from President-elect Donald Trump ...

Last week, billionaire and Dallas Mavericks owner Mark Cuban launched a new website that offers generic pharmaceutical drugs at a cheaper price than what’s available at most pharmacies. The company is called the Mark Cuban Cost Plus Drug Company (MCCPDC). MCCPDC will compete with pharmacy...

The Trump administration will no longer proceed with a large-scale overhaul of the drug-rebate industry. What Happened Pharmacy benefit managers (PBMs) negotiate a drug discount on behalf of health insurers and collect a commission for themselves as profit. Critics of the system argued it gives...

Diplomat Pharmacy Inc (NYSE: DPLO) on Friday reported its previously delayed fourth-quarter earnings miss and concerning guidance, which sent the stock tumbling nearly 14 percent. The Analysts Mizuho Securities' Ann Hynes maintains a Neutral rating on Diplomat Pharmacy with a price target...

Walmart Inc (NYSE: WMT) announced Friday a multi-year agreement to remain in the CVS Health Corp (NYSE: CVS) Caremark pharmacy benefit management program and Managed Medicaid retail pharmacy network. The extension ensures ongoing engagement between the companies, who maintain other agreements...

Amazon.com, Inc. (NASDAQ: AMZN) was reported last week to be building out a health and wellness team within its Alexa division to better integrate the assistant in health care. Loup Ventures considers this program just the start of a broader, three-pronged invasion of the $3.3 trillion industry....

Stocks representing the U.S. drug supply chain temporarily tumbled Friday as President Donald Trump proposed a broad plan to lower consumer health costs. These stocks recovered almost immediately as investors evaluated the unexpectedly benign strategy. His strategy includes: Equipping Medicare...

Anthem Inc (NYSE: ANTM) announced Wednesday its plans to launch an internal pharmacy-benefit manager at the 2019 expiration of its Express Scripts Holding Company (NASDAQ: ESRX) contract. The new unit, IngenioRx, will debut in 2020 through CVS Health Corp (NYSE: CVS) and is expected to yield more...

In a note published on Tuesday, Height Securities said it anticipates close scrutiny of DIR issues by policymakers would serve as an additional headwind for Pharmacy Benefit Managers, or PBMs. PBMs are intermediaries between insurance companies, pharmacies and manufacturers, working toward reducing...

Citron Research activist short seller and newsletter author Andrew Left has earned a reputation for accusing companies of fraud and deception and profiting off of their downfall. Left famously called out Valeant Pharmaceuticals Intl Inc (NYSE: VRX) in 2015 for its shady dealings with Philidor Rx...

Notwithstanding the broader market rally, pharmacy benefit managers, or PBMs, saw weakness on Wednesday amid fears that President Donald Trump has his eyes trained on this space. The reason? Trump is apparently suspecting these companies are colluding with drug manufacturers in jacking up prices...